Mesenchymal stromal tumor is gastrointestinal mesenchymal tumor, having gastrointestinal mesenchymal tumor is not a death sentence. Gastrointestinal mesenchymal tumor is a soft tissue sarcoma originated from the mesenchymal cells of the gastrointestinal tract, which may present with symptoms such as early satiety, dysphagia, abdominal distension, nausea, vomiting, etc. Most of the early stage mesenchymal tumors are benign. Most of the early gastrointestinal mesenchymal tumors are benign, and if there is no metastasis, the prognosis is generally good after timely treatment, so it is important for early intervention when you have intestinal mesenchymal tumors. After complete resection of gastrointestinal mesenchymal tumor patients, the 3-year survival rate can reach 75%, and the 5-year survival rate can reach 32% to 63%, and if postoperative adjuvant treatment with imatinib can further improve the overall survival rate of patients. Patients with gastrointestinal mesenchymal tumors should go to the hospital in time, under the guidance of the doctor for treatment, timely intervention and follow the doctor’s instructions to strictly use the medication, in order to avoid adverse effects.